Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027014 |
---|---|
Receipt number | R000030974 |
Scientific Title | The follow up study of "Phase l / ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type (JACCRO CC-06)". |
Date of disclosure of the study information | 2017/04/18 |
Last modified on | 2019/03/08 10:14:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/04/17 11:29:11 | ||
2 | Update | 2018/01/17 12:06:00 | Recruitment status |
|
3 | Update | 2019/03/08 10:14:22 | Recruitment status Date trial data considered complete Date analysis concluded |